Literature DB >> 27663871

Shared decision-making in multiple sclerosis.

Erica Colligan1, Abby Metzler1, Ezgi Tiryaki1.   

Abstract

In a healthcare environment that is trying to achieve better clinical outcomes and patient satisfaction, shared decision-making is a well-established concept that is gaining more interest. Multiple sclerosis is a preference-sensitive condition and provides the opportunity to implement decision aids at various decision points in the disease process. Literature about patient education and outcomes of shared decision aids in multiple sclerosis has been growing over the last decade. In this topical review, we present an overview of the current literature on shared decision-making in multiple sclerosis. While limitations to the generalizability and applicability of decision aids exist, there is evidence that decision aids and shared decision-making can be valuable tools in the clinical care of multiple sclerosis patients.

Entities:  

Keywords:  Multiple sclerosis; decision-making; decision-support techniques; patient-centered care

Mesh:

Year:  2016        PMID: 27663871     DOI: 10.1177/1352458516671204

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  20 in total

Review 1.  A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.

Authors:  Jeri Burtchell; Daisy Clemmons; Joann Clemmons; Tim Sabutis; Adeline Rosenberg; Jennifer Graves; Michael L Sweeney; John Kramer; Marina Ziehn; Brandon Brown; Jamie L Weiss; Ahmed Z Obeidat
Journal:  Neurol Ther       Date:  2022-05-24

2.  Evaluation of a pharmacist-led shared decision-making in atrial fibrillation and patients' satisfaction-a before and after pilot study.

Authors:  Viviane Khalil; Samantha Blackley; Ashwin Subramaniam
Journal:  Ir J Med Sci       Date:  2020-08-17       Impact factor: 1.568

3.  Impact of Shared Decision Making on Disease-Modifying Drug Adherence in Multiple Sclerosis.

Authors:  Aliza Ben-Zacharia; Meagan Adamson; Allison Boyd; Paula Hardeman; Jennifer Smrtka; Bryan Walker; Tracy Walker
Journal:  Int J MS Care       Date:  2018 Nov-Dec

4.  From Medical Prescription to Patient Compliance: A Qualitative Insight into the Neurologist-Patient Relationship in Multiple Sclerosis.

Authors:  Vincent Schlegel; Emmanuelle Leray
Journal:  Int J MS Care       Date:  2018 Nov-Dec

5.  The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement Policies.

Authors:  Katherine B Knox; Aman Saini; Michael C Levin
Journal:  Int J MS Care       Date:  2020 Mar-Apr

Review 6.  Shared Decision-making in Autoimmune Neurology: Making Decisions in the Face of Uncertainty.

Authors:  David A Lapides
Journal:  Neurol Clin Pract       Date:  2021-04

7.  "I Will Respect the Autonomy of My Patient": A Scoping Review of Shared Decision Making in Multiple Sclerosis.

Authors:  Anne Christin Rahn; Alessandra Solari; Heleen Beckerman; Richard Nicholas; David Wilkie; Christoph Heesen; Andrea Giordano
Journal:  Int J MS Care       Date:  2020-12-28

8.  Concordance Between Persons with Multiple Sclerosis and Treating Physician on Medication Effects and Health Status.

Authors:  Efrat Neter; Lea Glass-Marmor; Loren Haiien; Ariel Miller
Journal:  Patient Prefer Adherence       Date:  2021-05-07       Impact factor: 2.711

9.  Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot study.

Authors:  Angel Perez Sempere; Vanesa Vera-Lopez; Juana Gimenez-Martinez; Elena Ruiz-Beato; Jesús Cuervo; Jorge Maurino
Journal:  Patient Prefer Adherence       Date:  2017-05-29       Impact factor: 2.711

10.  Identifying priority outcomes that influence selection of disease-modifying therapies in MS.

Authors:  Gregory S Day; Alexander Rae-Grant; Melissa J Armstrong; Tamara Pringsheim; Stacey S Cofield; Ruth Ann Marrie
Journal:  Neurol Clin Pract       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.